Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.

Laboratories of Respiratory Biology, NIEHS, National Institutes of Health, United States Department of Health and Human Services, Research Triangle Park, North Carolina 27709, USA.
Molecular &amp Cellular Proteomics (Impact Factor: 7.25). 10/2008; 8(1):201-13. DOI: 10.1074/mcp.M800286-MCP200
Source: PubMed

ABSTRACT Lipopolysaccharide (LPS), a glycolipid component of the outer membrane of Gram-negative bacteria, is a potent initiator of the innate immune response of the macrophage. LPS triggers downstream signaling by selectively recruiting and activating proteins in cholesterol-rich membrane microdomains called lipid rafts. We applied proteomics analysis to macrophage detergent-resistant membranes (DRMs) during an LPS exposure time course in an effort to identify and validate novel events occurring in macrophage rafts. Following metabolic incorporation in cell culture of heavy isotopes of amino acids arginine and lysine ([(13)C(6)]Arg and [(13)C(6)]Lys) or their light counterparts, a SILAC (stable isotope labeling with amino acids in cell culture)-based quantitative, liquid chromatography-tandem mass spectrometry proteomics approach was used to profile LPS-induced changes in the lipid raft proteome of RAW 264.7 macrophages. Unsupervised network analysis of the proteomics data set revealed a marked representation of the ubiquitin-proteasome system as well as changes in proteasome subunit composition following LPS challenge. Functional analysis of DRMs confirmed that LPS causes selective activation of the proteasome in macrophage rafts and proteasome inactivation outside of rafts. Given previous reports of an essential role for proteasomal degradation of IkappaB kinase-phosphorylated p105 in LPS activation of ERK mitogen-activated protein kinase, we tested for a role of rafts in compartmentalization of these events. Immunoblotting of DRMs revealed proteasome-dependent activation of MEK and ERK specifically occurring in lipid rafts as well as proteasomal activity upon raft-localized p105 that was enhanced by LPS. Cholesterol extraction from the intact macrophage with methyl-beta-cyclodextrin was sufficient to activate ERK, recapitulating the LPS-IkappaB kinase-p105-MEK-ERK cascade, whereas both it and the alternate raft-disrupting agent nystatin blocked subsequent LPS activation of the ERK cascade. Taken together, our findings indicate a critical, selective role for raft compartmentalization and regulation of proteasome activity in activation of the MEK-ERK pathway.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Toll-like receptor 4 (TLR4) is activated by lipopolysaccharide (LPS), a component of Gram-negative bacteria to induce production of pro-inflammatory mediators aiming at eradication of the bacteria. Dysregulation of the host responses to LPS can lead to a systemic inflammatory condition named sepsis. In a typical scenario, activation of TLR4 is preceded by binding of LPS to CD14 protein anchored in cholesterol- and sphingolipid-rich microdomains of the plasma membrane called rafts. CD14 then transfers the LPS to the TLR4/MD-2 complex which dimerizes and triggers MyD88- and TRIF-dependent production of pro-inflammatory cytokines and type I interferons. The TRIF-dependent signaling is linked with endocytosis of the activated TLR4, which is controlled by CD14. In addition to CD14, other raft proteins like Lyn tyrosine kinase of the Src family, acid sphingomyelinase, CD44, Hsp70, and CD36 participate in the TLR4 signaling triggered by LPS and non-microbial endogenous ligands. In this review, we summarize the current state of the knowledge on the involvement of rafts in TLR4 signaling, with an emphasis on how the raft proteins regulate the TLR4 signaling pathways. CD14-bearing rafts, and possibly CD36-rich rafts, are believed to be preferred sites of the assembly of a multimolecular complex which mediates the endocytosis of activated TLR4.
    Cellular and Molecular Life Sciences CMLS 10/2014; 72(3). DOI:10.1007/s00018-014-1762-5 · 5.86 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Macrophages provide the first line of host defense by their capacity to react to an array of cytokines and bacterial components, requiring tight regulation of protein expression and secretion to invoke a properly tuned innate immune response. To capture the dynamics of this system, we introduce a novel method combining pulsed SILAC labeling with pulse-labeling using the methionine-analogue azidohomoalanine (AHA), allowing the enrichment of newly synthesized proteins via click-chemistry followed by their identification and quantification by mass spectrometry. We show that this permits the analysis of proteome changes at a rapid time scale evidenced by the detection of 4852 newly synthesized proteins after only a 20-minute SILAC pulse. We have applied this methodology to study proteome response during macrophage activation in a time-course manner. We have combined this with full proteome, transcriptome and secretome analyses producing an integrative analysis of the first 3 hours of lipopolysaccharides (LPS)-induced macrophage activation. We observed rapid induction of multiple processes well-known to TLR4 signaling, as well as anti-inflammatory proteins and proteins not associated with immune response before. By correlating transcriptional, translational and secretory events we derived novel mechanistic principles of processes specifically induced by LPS, including ectodomain shedding and proteolytic processing of transmembrane and extracellular proteins, and protein secretion independent of transcription. In conclusion, we demonstrate that the combination of pulsed AHA and pulsed SILAC labeling permits the detailed characterization of proteomic events at a rapid time scale. We anticipate that this approach will be very useful to probe immediate effects of cellular stimuli and to gain mechanistic insight of cellular perturbation in multiple biological systems. The data have been deposited to ProteomeXchange with identifier PXD000600.
    Molecular &amp Cellular Proteomics 01/2014; 13(3). DOI:10.1074/mcp.M113.030916 · 7.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pre-B cell colony enhancing factor (PBEF) is a highly conserved, pleiotropic protein reported to be an alternate ligand for the insulin receptor (IR). We evaluated the effects of PBEF on the localization of the IR β chain to lipid rafts in A549 epithelial cells. Methods: We isolated lipid rafts from A549 cells and detected the IR by immunoprecipitation from raft fractions or whole cell lysates. Cells were treated with rPBEF, its enzymatic product nicotinamide adenine dinucleotide (NAD), or the Nampt inhibitor, daporinad, to study the effect of PBEF on IRβ movement. We used co-immunoprecipitation studies in cells transfected with PBEF and IRβ constructs to detect interactions between PBEF, the IRβ, and caveolin-1 (Cav-1). Results: PBEF was present in both lipid raft and non-raft fractions, while the IR was only found in lipid raft fractions of resting A549 cells. The IR, PBEF and Cav-1 co-immunoprecipitated. rPBEF treatment resulted in the movement of IRβ and tyrosine phosphorylated Cav-1 from lipid rafts to non-rafts, an effect that could be blocked by daporinad, suggesting that this effect was facilitated by the Nampt activity of PBEF. The addition of PBEF to insulin-treated cells resulted in reduced Akt phosphorylation of both Ser473 and Thr308. Conclusions: PBEF can inhibit insulin signaling through the IR by Nampt-dependent promotion of IR translocation into the non-raft domains of A549 epithelial cells. PBEF-induced alterations in the spatial geometry of the IR provide a mechanistic explanation for insulin resistance in inflammatory states associated with upregulation of PBEF. Copyright © 2014, American Journal of Physiology - Endocrinology and Metabolism.
    AJP Endocrinology and Metabolism 12/2014; 308(4):ajpendo.00006.2014. DOI:10.1152/ajpendo.00006.2014 · 4.09 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014